References
- Bellail AC, Tse MC, Song JH, et al (2010). DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. J Cell Mol Med, 14, 1303-17. https://doi.org/10.1111/j.1582-4934.2009.00777.x
- Bellail AC, Olson JJ, Yang X, et al (2012). A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma. Cancer Discov, 2, 140-55. https://doi.org/10.1158/2159-8290.CD-11-0172
- Capper D, Gaiser T, Hartmann C, et al (2009). Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation. Acta Neuropathol, 117, 445-56. https://doi.org/10.1007/s00401-009-0494-3
- Ding LJ, Yuan CJ, Wei F, et al (2011). Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP. Cancer Invest, 29, 511-520. https://doi.org/10.3109/07357907.2011.605412
- Dirks PB (2010). Brain cancer stem cells: the cancer stem cell hypothesis writ large. Mol Oncol, 4, 420-30. https://doi.org/10.1016/j.molonc.2010.08.001
- Gao CM, Ding JH, Li SP, et al (2013). Polymorphisms in XRCC1 gene, alcohol drinking, and risk of colorectal cancer: a case-control study in Jiangsu Province of China. Asian Pac J Cancer Prev, 14, 6613-8. https://doi.org/10.7314/APJCP.2013.14.11.6613
- Li YC, Tzeng CC, Song JH, et al (2006). Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy. Clin Cancer Res, 12, 2716-29. https://doi.org/10.1158/1078-0432.CCR-05-1980
- Li Z, Bao S, Wu Q, et al (2009). Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell, 15, 501-13. https://doi.org/10.1016/j.ccr.2009.03.018
- Qi L, Bellail AC, Rossi MR, et al (2011a). Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis. Apoptosis, 16, 1150-64. https://doi.org/10.1007/s10495-011-0645-6
- Qi L, Jin H, Ding LJ, et al (2011b). CD133 magnetic sorting and biological characteristics of brain cancer stem cells. Jo Jilin University (Medicine Edition), 37, 441-4.
- Qi L, Yu HQ, Ding LJ, et al (2011c). Role of caspase-8 in glioblastoma resistance to TRAIL-induced apoptosis. J Jilin University (Medicine Edition), 37, 612-6.
- Qi L, Jin H, Zhao DH, et al (2014). Effect of schisandra lignans on the apoptosis of SHG-44 glioma neurospheres. Chin Pharm J, 49, 113-6.
- Qiu B, Wang Y, Tao J, et al (2012). Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells. Oncol Rep, 28, 155-60.
- Singh SK, Hawkins C, Clarke ID, et al (2004). Identification of human brain tumour initiating cells. Nature, 432, 396-401. https://doi.org/10.1038/nature03128
- Wang R, Chadalavada K, Wilshire J, et al (2010). Glioblastoma stem-like cells give rise to tumour endothelium. Nature, 468, 829-33. https://doi.org/10.1038/nature09624
- Yuan X, Curtin J, Xiong Y, et al (2004). Isolation of cancer stemcells from adult glioblastoma multiforme. Oncogene, 23, 9392-400. https://doi.org/10.1038/sj.onc.1208311
- Zhao XD, He YY, Gao J, et al (2014). High expression of bcl-2 protein predicts favorable outcome in non-small cell lung cancer: evidence from a systematic review and meta-analysis. Asian Pac J Cancer Prev, 15, 8861-9. https://doi.org/10.7314/APJCP.2014.15.20.8861
- Zheng NG, Mo SJ, Li JP, et al (2014). Anti-CSC effects in human esophageal squamous cell carcinomas and eca109/9706 cells induced by nanoliposomal quercetin alone or combined with CD 133 antiserum. Asian Pac J Cancer Prev, 15, 8879-84.
Cited by
- Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour vol.19, pp.8, 2018, https://doi.org/10.3390/ijms19082188